Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCICtrial. Lancet Oncol 10:459-466 3

Article  CAS  PubMed  Google Scholar 

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

Article  CAS  PubMed  Google Scholar 

Nael K, Bauer AH, Hormigo A et al (2018) Multiparametric MRI for differentiation of radiation necrosis from recurrent tumor in patients with treated glioblastoma. AJR Am J Roentgenol 210:18–23

Article  PubMed  Google Scholar 

Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453–461

Article  PubMed  Google Scholar 

Ellingson BM, Wen PY, Cloughesy TF (2017) Modified criteria for radiographic response assessment in glioblastoma clinical trials. Neurother J Am Soc Exp Neurother 14:307–320

Google Scholar 

Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma—Are we there yet? Neuro Oncol 15:4–27

Article  PubMed  Google Scholar 

Lee J, Chen MM, Liu HL, Ucisik FE, Wintermark M, Kumar VA (2024) Mr perfusion imaging for gliomas. Magn Reson Imaging Clin N Am 32:73–83

Article  PubMed  Google Scholar 

Feng A, Yuan P, Huang T, Li L, Lyu J (2022) Distinguishing tumor recurrence from radiation necrosis in treated glioblastoma using multiparametric MRI. Acad Radiol 29:1320–1331

Article  PubMed  Google Scholar 

Bobek-Billewicz B, Heinze S, Awramienko-Wloczek A, Majchrzak K, Nowicka E, Hebda A (2023) The use of MR perfusion parameters in differentiation between glioblastoma recurrence and radiation necrosis. Folia Neuropathol 61:371–378

Article  PubMed  Google Scholar 

Panholzer J, Malsiner-Walli G, Grün B, Kalev O, Sonnberger M, Pichler R (2024) Multiparametric analysis combining DSC-MR perfusion and [18F]FET-PET is superior to a single parameter approach for differentiation of progressive glioma from radiation necrosis. Clin Neuroradiol 34:351–360

Article  PubMed  Google Scholar 

Gu X, He X, Wang H, Li J, Chen R, Liu H (2024) Dynamic susceptibility contrast-enhanced perfusion-weighted imaging in differentiation between recurrence and pseudoprogression in high-grade glioma: a meta-analysis. J Comput Assist Tomogr 48:303–310

Article  PubMed  Google Scholar 

Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193:637–641

Article  CAS  PubMed  Google Scholar 

Barajas RF Jr, Chang JS, Segal MR et al (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 253:486–496

Article  PubMed  PubMed Central  Google Scholar 

Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M (2015) ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. Am J Neuroradiol 36:E41–E51

Article  CAS  PubMed  PubMed Central  Google Scholar 

Essig M, Nguyen TB, Shiroishi MS et al (2013) Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol 201:W495-510

Article  PubMed  Google Scholar 

Zhang J, Wang Y, Wang Y et al (2022) Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression. Quant Imaging Med Surg 12:4805–4822

Article  PubMed  PubMed Central  Google Scholar 

Alsop DC, Detre JA, Golay X et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the SMRM Perfusion Study Group and the European Consortium for ASL in dementia. Magn Reson Med 73:102–116

Article  PubMed  Google Scholar 

Lindner T, Bolar DS, Achten E et al (2023) Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging. Magn Reson Med 89:2024–2047

Article  PubMed  PubMed Central  Google Scholar 

Wang Y-L, Chen S, Xiao H-F et al (2018) Differentiation between radiation-induced brain injury and glioma recurrence using 3D PCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging. Radiother Oncol 129(68–74):33

Google Scholar 

Xu Q, Liu Q, Ge H et al (2017) Tumor recurrence versus treatment effects in glioma: a comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Medicine 96(50):e9332

Article  PubMed  PubMed Central  Google Scholar 

Ye J, Bhagat SK, Li H et al (2016) Differentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imaging. Exp Ther Med 11:2432–243635

Article  PubMed  PubMed Central  Google Scholar 

Jovanovic M, Radenkovic S, Stosic-Opincal T et al (2017) Differentiation between progression and pseudoprogression by arterial spin labeling MRI in patients with glioblastoma multiforme. J BUON 22:1061–1067

PubMed  Google Scholar 

Choi YJ, Kim HS, Jahng G-H, Kim SJ, Suh DC (2013) Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging. Acta Radiol 54:448–454

Article  PubMed  Google Scholar 

Nguyen TB, Zakhari N, Velasco Sandoval S et al (2023) Diagnostic accuracy of arterial spin-labeling, dynamic contrast-enhanced, and DSC perfusion imaging in the diagnosis of recurrent high-grade gliomas: a prospective study. AJNR Am J Neuroradiol 44:134–142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soni N, Ora M, Mohindra N, Menda Y, Bathla G (2020) Diagnostic performance of PET and perfusion-weighted imaging in differentiating tumor recurrence or progression from radiation necrosis in posttreatment gliomas: a review of literature. AJNR Am J Neuroradiol 41:1550–1557

CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Wu Y, Wang Y, Zhang X, Lei Y, Zhu G, Mao C, Zhang L, Ma L (2023) Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence. Eur Radiol 33:3332–3342

Article  PubMed  Google Scholar 

Hou H, Diao Y, Yu J, Xu M, Wang L, Li Z, Song T, Liu Y, Yuan Z (2023) Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI. NMR Biomed 36:e4821

Article  CAS  PubMed  Google Scholar 

Herrmann K, Czernin J, Cloughesy T et al (2014) Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro-Oncol 16:603–609

Article  PubMed  Google Scholar 

Zaragori T, Ginet M, Marie PY et al (2020) Use of static and dynamic [18F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression. EJNMMI Res 29(10):56

Article  Google Scholar 

Seeger A, Braun C, Skardelly M et al (2013) Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Acad Radiol 20:1557–1565

Article  PubMed  Google Scholar 

Morabito R, Alafaci C, Pergolizzi S et al (2019) DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife. Radiat Oncol 15(14):65

Article  Google Scholar 

Manning P, Daghighi S, Rajaratnam MK et al (2020) Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma. J Neurooncol 147:681–690

Article  PubMed  Google Scholar 

Haller S, Zaharchuk G, Thomas DL, Lovblad K, Barkhof F, Golay X (2016) Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology 281:337–356

Article  PubMed  Google Scholar 

Henriksen OM, Del Mar Á-T, Figueiredo P, Hangel G, Keil VC, Nechifor RE, Riemer F, Schmainda KM, Warnert EAH, Wiegers EC, Booth TC (2022) High-grade glioma treatment response monitoring biomarkers: a position statem